CARDENE I.V. drug interactions: Difference between revisions
Created page with "__NOTOC__ {{Nicardipine}} {{CMG}}; {{AE}}:{{AK}} '''''For patient information about Nicardipine, click here.''''' ==DRUG INTERACTIONS==..." |
No edit summary |
||
| Line 21: | Line 21: | ||
===In Vitro Interaction=== | ===In Vitro Interaction=== | ||
The plasma protein binding of nicardipine was not altered when therapeutic concentrations of [[furosemide]], [[propranolol]], [[dipyridamole]], [[warfarin]], [[quinidine]], or [[naproxen]] were added to human plasma in vitro. | The plasma protein binding of nicardipine was not altered when therapeutic concentrations of [[furosemide]], [[propranolol]], [[dipyridamole]], [[warfarin]], [[quinidine]], or [[naproxen]] were added to human plasma in vitro.<ref> {{cite web | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f8ef8420-01d2-11de-a455-0002a5d5c51b | title = CARDENE I.V. (nicardipine hydrochloride) injection, solution [EKR Therapeutics, Inc.] |accessdate = }}</ref> | ||
==References== | |||
{{Reflist|2}} | {{Reflist|2}} | ||
{{FDA}} | |||
[[Category:Cardiovascular Drugs]] | [[Category:Cardiovascular Drugs]] | ||
[[Category:Drugs]] | [[Category:Drugs]] | ||
Revision as of 16:32, 20 February 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: :Abdurahman Khalil, M.D. [2]
For patient information about Nicardipine, click here.
DRUG INTERACTIONS
Beta-Blockers
In most patients, Cardene I.V. Premixed Injection can safely be used concomitantly with beta blockers. However, titrate slowly when using Cardene I.V. Premixed Injection in combination with a beta-blocker in heart failure patients [see Warnings and Precautions (5.3)].
Cimetidine
Cimetidine has been shown to increase nicardipine plasma concentrations with oral nicardipine administration. Frequently monitor response in patients receiving both drugs. Data with other histamine-2 antagonists are not available.
Cyclosporine
Concomitant administration of oral nicardipine and cyclosporine results in elevated plasma cyclosporine levels. Closely monitor plasma concentrations of cyclosporine during Cardene I.V. Premixed Injection administration, and reduce the dose of cyclosporine accordingly.
In Vitro Interaction
The plasma protein binding of nicardipine was not altered when therapeutic concentrations of furosemide, propranolol, dipyridamole, warfarin, quinidine, or naproxen were added to human plasma in vitro.[1]
References
Adapted from the FDA Package Insert.